title: Cardiac risk and perioperative management.
abstract: Cardiovascular complications are the major cause of perioperative and late morbidity and mortality in patients undergoing major vascular surgery. This is related to the frequent presence of underlying coronary artery disease (CAD). CAD may be asymptomatic because of reduced exercise capacity due to pre-existing non-cardiac conditions like stroke or claudication. Careful preoperative evaluation of CAD and perioperative management with beta-blockers and statins may offer the physician a unique opportunity to improve patients' perioperative and long-term outcome.
authors.affiliation: Department of Cardiology, Erasmus Medical Centre, Rotterdam, The Netherlands.
authors.forename: M D
authors.initials: MD
authors.lastname: Kertai
authors.forename: D
authors.initials: D
authors.lastname: Poldermans
authors.forename: J J
authors.initials: JJ
authors.lastname: Bax
authors.forename: J
authors.initials: J
authors.lastname: Klein
authors.forename: H
authors.initials: H
authors.lastname: Van Urk
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000924:Anticholesteremic Agents / Q000008:administration & dosage; D002423:Cause of Death; D003327:Coronary Disease / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage; D009204:Myocardial Revascularization; D019990:Perioperative Care / Q000379:methods*; D011183:Postoperative Complications / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D011379:Prognosis; D018570:Risk Assessment; D015996:Survival Rate; D014656:Vascular Surgical Procedures
chemical_list: D000319:Adrenergic beta-Antagonists; D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors